These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 407312)

  • 21. Intranasal infection of monkeys with Japanese encephalitis virus: clinical response and treatment with a nuclease-resistant derivative of poly (I).poly (C).
    Harrington DG; Hilmas DE; Elwell MR; Whitmire RE; Stephen EL
    Am J Trop Med Hyg; 1977 Nov; 26(6 Pt 1):1191-8. PubMed ID: 202173
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of interferon responses to poly ICLC in males and females.
    Bever CT; McFarlin DE; Levy HB
    J Interferon Res; 1992 May; Spec No():85-90. PubMed ID: 1379290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyriboinosinic-polyribocytidylic acid-poly-L-lysine complex [poly(ICL)] without carboxymethylcellulose (CMC): a new primate-effective interferon inducer.
    Riley FL; Morin ML; Lvovsky E; Stephens EE; Levy HB
    Proc Soc Exp Biol Med; 1982 Feb; 169(2):183-8. PubMed ID: 6174989
    [No Abstract]   [Full Text] [Related]  

  • 24. Serological reactions in Rhesus monkeys inoculated with the 17D strain of yellow fever virus.
    GROOT H
    Bull World Health Organ; 1962; 27(6):709-15. PubMed ID: 13950709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of poly-ICLC against Ebola-Zaire virus (EBOV) infection in mice and cynomolgus monkeys.
    Kende M; Paragas J; Salazar AM
    Antiviral Res; 2019 Mar; 163():179-184. PubMed ID: 30611774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of the antiviral activity of a poly I : poly-C complex with poly-L-lysine in monkeys].
    Burgasova MP
    Antibiotiki; 1977 May; 22(5):458-60. PubMed ID: 406827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranking of prophylactic efficacy of poly(ICLC) against Rift Valley fever virus infection in mice by incremental relative risk of death.
    Kende M; Lupton HW; Rill WL; Gibbs P; Levy HB; Canonico PG
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1194-8. PubMed ID: 3631943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interferon induction in monkeys by poly I-C complex with poly-L-lysine].
    Bektemirov TA; Burgasova MP; Andzhaparidze OG
    Vopr Virusol; 1976; (5):536-9. PubMed ID: 827121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice.
    Kende M
    J Biol Response Mod; 1985 Oct; 4(5):503-11. PubMed ID: 2416883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortisol induction by poly ICLC: implications for clinical trials of interferon.
    Bever CT; McFarland HF; Levy HB; McFarlin DE
    Ann Neurol; 1988 Feb; 23(2):196-9. PubMed ID: 2454067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of a complex of poly(I). poly(C) and poly-l-lysine on the course of vaccinia in monkeys].
    Andzhaparidze OG; Bektemirov TA; Burgasova MP
    Vopr Virusol; 1977; (3):339-43. PubMed ID: 410162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
    Guirakhoo F; Zhang Z; Myers G; Johnson BW; Pugachev K; Nichols R; Brown N; Levenbook I; Draper K; Cyrek S; Lang J; Fournier C; Barrere B; Delagrave S; Monath TP
    J Virol; 2004 Sep; 78(18):9998-10008. PubMed ID: 15331733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum lactate dehydrogenase of normal, stressed, and yellow fever virus-infected rhesus monkeys.
    Scott SK; Kosch PC; Hilmas DE
    Lab Anim Sci; 1976 Jun; 26(3):436-42. PubMed ID: 820921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of a poly I-poly C complex with poly-L-lysine on experimental tick-borne encephalitis].
    Burgasova MP; Andzhaparidze OG; Bektemirov TA; Bogomolova NN; Boriskin IuS
    Vopr Virusol; 1977; (4):438-41. PubMed ID: 411260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A yellow fever epizootic in Zika forest, Uganda, during 1972: Part 1: Virus isolation and sentinel monkeys.
    Kirya BG
    Trans R Soc Trop Med Hyg; 1977; 71(3):254-60. PubMed ID: 407675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of human gamma interferon on yellow fever virus infection.
    Arroyo JI; Apperson SA; Cropp CB; Marafino BJ; Monath TP; Tesh RB; Shope RE; Garcia-Blanco MA
    Am J Trop Med Hyg; 1988 May; 38(3):647-50. PubMed ID: 3152785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of interferon in prophylaxis of rabies after exposure.
    Wiktor TJ; Koprowski H; Mitchell JR; Merigan TC
    J Infect Dis; 1976 Jun; 133 Suppl():A260-5. PubMed ID: 819599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modified polyriboinosinic-polyribocytidylic acid complex: induction of serum interferon, fever, and hypotension in rabbits.
    Gatmaitan BG; Legaspi RC; Levy HB; Lerner AM
    Antimicrob Agents Chemother; 1980 Jan; 17(1):49-54. PubMed ID: 7352750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin.
    Jahrling PB; Hesse RA; Eddy GA; Johnson KM; Callis RT; Stephen EL
    J Infect Dis; 1980 May; 141(5):580-9. PubMed ID: 6768812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plant-Produced Subunit Vaccine Candidates against Yellow Fever Induce Virus Neutralizing Antibodies and Confer Protection against Viral Challenge in Animal Models.
    Tottey S; Shoji Y; Jones RM; Chichester JA; Green BJ; Musiychuk K; Si H; Manceva SD; Rhee A; Shamloul M; Norikane J; Guimarães RC; Caride E; Silva ANMR; Simões M; Neves PCC; Marchevsky R; Freire MS; Streatfield SJ; Yusibov V
    Am J Trop Med Hyg; 2018 Feb; 98(2):420-431. PubMed ID: 29231157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.